46 results found.
BARE BONES® - January 16, 2014
Medicrea posted 4Q13 sales of €5.8MM (~US $7.9MM), +18% from 4Q12, and 2013 sales of €22.9MM (~$31.2MM), +11% from 2012. (Full-year U.S. +25% vs. 20...
4Q13/2013 Revenue: Medicrea
4Q13 revenue: €5.8MM (~US $7.9MM), +18% (U.S. $4.5MM) Resubmitted to FDA the approval file for K-JAWS cervical compression staple   2013 revenue: €22.9MM (~$31.2MM), +11% (U.S. +25%) For 2014, co...
BARE BONES® - October 23, 2013
MEDICREA posted 3Q13 sales of €5.2MM (~US $7.2MM), +4% from 3Q12. (The MEDICREA Group, 10/23/13)
3Q13 Revenue: Medicrea
€5.2MM (~US $7.2MM), +4% (U.S. +29%) >60% of sales attributed to U.S. market Accelerating U.S. growth via direct and indirect distribution networks
BARE BONES® - July 12, 2013
Medicrea posted 1H13 sales of €11.9MM (~US $15.5MM), +10% from 1H12, with U.S. sales +20%. (
2Q13 Revenue: Medicrea
(1H13 revenue) €11.9MM (~US $15.5MM), +10% (U.S. sales +20%) Launched distribution in 4 more countries in Asia since start of year Meeting with FDA by end of July regarding status of K-JAWS cervical compressive staple ...
BARE BONES® - April 12, 2013
Medicrea posted 1Q13 sales of €5.3MM (~US $7MM), +11% from 1Q12. (U.S. subsidiary +22%) (Medicr...
4Q12 and 2012 Revenue: Medicrea
€20.7MM (~US $27.4MM), +9% 4Q12 revenue: $6.5MM, +20% (U.S. +41%) Expecting recovery of U.S. economic activity in 2013 PASS LP thoracolumbar fixation system >80% of sales Commenced negotiations with U.S. partners to dis...
BARE BONES® - January 16, 2013
Medicrea posted 2012 sales of €20.7MM (~US $27.4MM), +9% from 2011. The company's U.S. subsidiary 4Q12 sales grew 41% over 4Q11. (
BARE BONES® - October 12, 2012
MEDICREA posted 3Q12 sales of €5.0MM (~US $6.4MM), +25% from 3Q11. (The MEDICREA Group, 10/12/12)
3Q12 Earnings: Medicrea
€5.0MM (~US $6.4MM), +25% Launched final stage of validation protocol for K-JAWS implant, hopeful for FDA clearaing in 1Q13
2Q12: A First Look at Earnings
ORTHOWORLD’s estimates place preliminary 2Q12 market growth at 5% over 2Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 2Q12, unless otherwise noted. Exhibit 1 Orthopaedic Sales Increas...
BARE BONES® - July 13, 2012
Medicrea posted 1H12 sales of €10.8MM (~US $13.1MM), +32% from 1H11, and 2Q12 sales of ~$7.3MM, +3% from 2Q11. (
First Look at Quarterly Results: 1Q12 vs. 1Q11
ORTHOWORLD’s preliminary estimates place overall 1Q12 market growth at 3% over 1Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 1Q12, unless noted otherwise. Exhibit 1 Orthopaedic Sales1 Increase...
BARE BONES® - April 6, 2012
Medicrea posted 1Q12 sales of €4.9MM (~$6.4MM), +20% from 1Q11. (Medicrea, 4/6/12) ...
The Next Look at 2011 Results
ORTHOWORLD’s preliminary estimates place overall 2011 market growth at 5% over 2010, as displayed in Exhibit 1. Performance highlights follow, and address both 4Q10 and 2011, as indicated.                                      ...
3Q11: A First Look at Financials: Medicrea
MEDICREA €4.0MM (~US $5.5MM), -13% * PASS-LP polyaxial system accounts for ~75% of revenue * Low growth partially attributed to time taken to get new sales staff up to speed * Unveiled 6 new products, including GRANVIA-L hybrid lumbar di...
First Look at 2Q11 Results: Medicrea
MEDICREA €5.8MM (~US $8.2MM), +29% * Best performance to date for U.S. subsidiary, mainly attributable to PASS LP thoracolumbar fixation system
First Look at 1Q11 Results: Medicrea
MEDICREA €5.2MM (~US $7.4MM), +53% * U.S. sales ~50% of activity
Orthopaedic Sales Increases By Product Segment: 2010 vs. 2009

A First Look at 2010 Results: Medicrea
MEDICREA * €18.2MM (~US $24.3MM), +39% (U.S. ~$12MM, +50%) * PASS LP platform = ~75% of group sales * Granvia C cervical disc = 5% of group sales * 250 patients treated to date using Granvia C
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group